Chlorpheniramine maleate; phenylpropanolamine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for chlorpheniramine maleate; phenylpropanolamine hydrochloride and what is the scope of patent protection?
Chlorpheniramine maleate; phenylpropanolamine hydrochloride
is the generic ingredient in three branded drugs marketed by Graham Dm and Novartis, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.Summary for chlorpheniramine maleate; phenylpropanolamine hydrochloride
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 2 |
| NDAs: | 3 |
| DailyMed Link: | chlorpheniramine maleate; phenylpropanolamine hydrochloride at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for chlorpheniramine maleate; phenylpropanolamine hydrochloride
US Patents and Regulatory Information for chlorpheniramine maleate; phenylpropanolamine hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Graham Dm | COLD CAPSULE V | chlorpheniramine maleate; phenylpropanolamine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018794-001 | Apr 23, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novartis | TRIAMINIC-12 | chlorpheniramine maleate; phenylpropanolamine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 018115-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Graham Dm | COLD CAPSULE IV | chlorpheniramine maleate; phenylpropanolamine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018793-001 | Apr 25, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
